Header cover image

French (CAC) Pharma Industry Analysis

UpdatedJul 27, 2024
DataAggregated Company Financials
Companies8
  • 7D3.9%
  • 3M4.8%
  • 1Y0.6%
  • YTD5.1%

The Pharma industry is up 3.9% in the last week, with Sanofi up 4.8%. During this same period, the Ipsen underperformed, falling 5.6%. Overall in the last year, the industry is flat. Looking forward, earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the French Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Jul 2024€134.5b€53.7b€4.9b21.6x27.5x2.5x
Mon, 24 Jun 2024€123.9b€52.9b€5.2b20.3x24x2.3x
Wed, 22 May 2024€127.7b€52.9b€5.2b21.7x24.7x2.4x
Fri, 19 Apr 2024€120.3b€52.7b€6.0b19.7x19.9x2.3x
Sun, 17 Mar 2024€123.7b€52.6b€6.0b20.4x20.5x2.4x
Tue, 13 Feb 2024€121.7b€53.0b€6.3b19.5x19.4x2.3x
Thu, 11 Jan 2024€133.1b€52.2b€9.7b19.4x13.7x2.5x
Sat, 09 Dec 2023€121.2b€52.2b€9.7b16.8x12.5x2.3x
Mon, 06 Nov 2023€120.7b€52.2b€9.7b16.1x12.4x2.3x
Wed, 04 Oct 2023€143.1b€52.6b€9.3b18.8x15.4x2.7x
Fri, 01 Sep 2023€139.0b€52.6b€9.3b21x15x2.6x
Sun, 30 Jul 2023€133.9b€52.7b€9.2b20.2x14.5x2.5x
Tue, 27 Jun 2023€136.0b€52.6b€9.1b15.2x14.9x2.6x
Thu, 25 May 2023€140.4b€52.6b€9.1b15.6x15.4x2.7x
Sat, 22 Apr 2023€142.5b€51.8b€9.2b15.3x15.6x2.8x
Mon, 20 Mar 2023€125.7b€51.7b€9.2b14.4x13.7x2.4x
Wed, 15 Feb 2023€124.4b€51.7b€7.5b18.4x16.5x2.4x
Fri, 13 Jan 2023€127.1b€50.7b€7.4b17.7x17.3x2.5x
Sun, 11 Dec 2022€125.0b€50.7b€7.4b17.5x17x2.5x
Tue, 08 Nov 2022€122.6b€50.7b€7.4b17.1x16.7x2.4x
Thu, 06 Oct 2022€114.9b€48.4b€7.6b17.7x15.1x2.4x
Sat, 03 Sep 2022€116.9b€48.2b€7.6b24.3x15.4x2.4x
Mon, 01 Aug 2022€136.7b€48.2b€7.6b23.1x18.1x2.8x
Wed, 29 Jun 2022€138.0b€46.3b€7.5b22.1x18.4x3x
Fri, 27 May 2022€144.0b€45.4b€7.5b23.5x19.2x3.2x
Sun, 24 Apr 2022€141.1b€44.2b€7.1b23.9x20x3.2x
Tue, 22 Mar 2022€131.3b€44.1b€7.1b20.5x18.5x3x
Thu, 17 Feb 2022€130.6b€44.1b€7.1b18.9x18.5x3x
Sat, 15 Jan 2022€126.2b€43.2b€7.0b20x18x2.9x
Mon, 13 Dec 2021€122.1b€43.2b€7.0b22.5x17.4x2.8x
Wed, 10 Nov 2021€124.1b€43.2b€7.0b21.2x17.8x2.9x
Fri, 08 Oct 2021€118.2b€42.3b€6.6b18.8x17.9x2.8x
Sun, 05 Sep 2021€122.8b€42.2b€6.6b21.9x18.6x2.9x
Tue, 03 Aug 2021€121.5b€42.2b€6.6b20.9x18.4x2.9x
Price to Earnings Ratio

18.4x


Total Market Cap: €121.5bTotal Earnings: €6.6bTotal Revenue: €42.2bTotal Market Cap vs Earnings and Revenue0%0%0%
French Pharma Industry Price to Earnings3Y Average 17.4x202220232024
Current Industry PE
  • Investors are optimistic on the French Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 27.5x which is higher than its 3-year average PE of 17.4x.
  • The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 9.4% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the French Healthcare industry?

FR Market0.042%
Healthcare6.14%
Pharma3.94%
Pharma3.94%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SAN Sanofi€96.824.8%
+€5.6b
2.0%PE28.7x
EAPI Euroapi€3.3510.0%
+€29.0m
-69.1%PS0.3x
VETO Vetoquinol€101.201.5%
+€17.7m
7.9%PE21.6x
MEDCL MedinCell€15.561.2%
+€5.2m
147.0%PS37.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IPN

€103.20

Ipsen

7D

-5.6%

1Y

-10.3%

SAN

€96.82

Sanofi

7D

4.8%

1Y

2.0%

VIRP

€346.50

Virbac

7D

-0.7%

1Y

18.9%

EAPI

€3.35

Euroapi

7D

10.0%

1Y

-69.1%

ALDVI

€0.91

Advicenne

7D

-26.3%

1Y

-74.4%

AB

€1.03

AB Science

7D

-2.8%

1Y

-73.3%

BOI

€32.40

Boiron

7D

-0.6%

1Y

-35.6%